Phase 2 study of perioperative lenvatinib (L) with pembrolizumab (P) in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2025 ...

designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures ... augmentation, radiofrequency ablation, and bone biopsy ...

Revenue for Q4 2024 was $1.34 billion, surpassing the estimate by $25 million. Adjusted EPS was $0.05, missing expectations by $0.12. Net income improved to $33 million from a loss of $36 million ...

The latter is possible because of the use of the very high-frequency current of 4 MHz, vs the 0.5-1.5 MHz energy used in the electrocautery procedure. In contrast to true cautery, which causes ...

CFO Gary Corona reported Q3 revenue of $8.3 billion with adjusted EPS of $1.39. He noted, "The EPS beat was driven by better-than-expected operating profit on stronger gross margins and a better ...

A Philadelphia jury awarded $153,750 to a motor vehicle plaintiff. The plaintiffs had valued the case in the millions of dollars during settlement negotiations. An attorney for the defendant ...

KPJ Kluang Specialist Hospital (“KPJ Kluang”) has achieved a significant milestone in cardiac care by successfully performing the region’s first Cryoballoon Ablation procedure combined with ...

The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum. Percentages have been calculated using actual, non-rounded figures and, therefore, may not ...